FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
, , Dilip Davda, , and have given "Apply" recommendation to Advanced Enzyme IPO.
Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
---|---|---|---|---|---|
Count | 6 | 0 | 0 | 0 | 0 |
% | 100.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Reviewer | Recommendation | Past Reviews |
---|---|---|
Apply | ||
Apply | ||
Dilip Davda | Apply | |
Apply | ||
Apply | ||
Apply |
The Captial Market (CapitalMarket.com) rating for Advanced Enzyme IPO is 47. Their analysis recommends May subscribe for the IPO.
Reviewer | Rating Score | Rating |
---|---|---|
Capital Market | 47 | May subscribe |
[Dilip Davda] Being first mover IPO in the enzymes segment, it is catching fancy. Considering its track records and future prospects ahead, investors may consider investment for short to long term rewards. Read detail review...
Post Recommendation Manage Recommendations
Note:
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|